Human Papillomaviruses (HPV) Infection: How to Treat and Prevent?

Dear Colleagues,

Human papillomavirus (HPV) is so prevalent that every sexually active person is at risk without vaccination. HPV fades in most cases (9 out of 10) within two years without health problems. However, when HPV remains, it can cause health problems, such as genital warts and cancer. There is no way of knowing who will develop these more severe outcomes. People with weak immune systems (including those with HIV) may be less able to fight off HPV. They may also be more likely to develop health problems from HPV. The HPV vaccine is safe and effective and can protect against diseases (including cancers) caused by HPV when administered to the recommended age groups. There is no treatment for the virus itself. However, there are treatments for the health problems that HPV can cause. This Special Issue aims to publish a broad range of articles covering topics including (but not limited to) immune responses, transmission, epidemiology, pathogenicity, vaccines, and treatments related of HPV. A wide range of manuscripts, including research articles, communications, and reviews, are welcome. We are particularly interested in emerging new concepts in this field.

Dr. Giulia Ciccarese
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Clinical Medicine is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.